IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer
Longyong Xu(Shanghai Institutes for Biological Sciences), Xi Chen(Baylor College of Medicine), Anthony M. Mustoe(Baylor College of Medicine), Meng C. Wang(Howard Hughes Medical Institute), Xin Fu(AstraZeneca (United Kingdom)), Susan M. Rosenberg(Baylor College of Medicine), C. Kent Osborne(Baylor College of Medicine), George Miles(Baylor College of Medicine), Ralf B. Nehring(Baylor College of Medicine), Thomas F. Westbrook(Baylor College of Medicine), Matthew J. Ellis(University of California, Davis), Lacey E. Dobrolecki(Baylor College of Medicine), Fei Yuan(Population Health Research Institute), Bert W. O’Malley(Baylor College of Medicine), Sophie S. Zhang(Rice University), Xiangdong Lv(National University of Defense Technology), Yao Ding(The University of Texas MD Anderson Cancer Center), Albert C. Koong(The University of Texas MD Anderson Cancer Center), Weiyi Peng(University of Houston), Jin Billy Li(Shanghai University), Fanglue Peng(Baylor College of Medicine), Doug Graham(Baylor College of Medicine), Mothaffar F. Rimawi(Baylor College of Medicine), Qianzi Tang(Tongji University), Xiang H.-F. Zhang(Baylor College of Medicine), Jeffrey M. Rosen(Baylor College of Medicine), Ayse Sena Mutlu(Baylor College of Medicine), Xingyu Li(Sichuan Agricultural University), Weijie Zhang(Soochow University), Zhibin Zhang(The University of Texas MD Anderson Cancer Center), Bing Zhang(Baylor College of Medicine), Rui Chen(University of California, Irvine), Yiwen Chen(Third Affiliated Hospital of Zhengzhou University), Wei He(Jiangsu Normal University), Yumei Li(Qingdao University), Jingyi Wang(China National Nuclear Corporation), Qin Luo(People's Hospital of Xinjiang Uygur Autonomous Region), Dong Han(Baylor College of Medicine), Jin Liu(Xijing Hospital), Shuyue Wang(Second Affiliated Hospital of Zhejiang University), Catherine Li(Broad Institute), Wei-Che Wu(The University of Texas MD Anderson Cancer Center), Na Zhao(Shanxi University), Han Xu(The University of Texas MD Anderson Cancer Center), Michael T. Lewis(Baylor College of Medicine), Eric J. Jaehnig(Baylor College of Medicine), Liting Zheng(Beijing Institute of Technology), André Catic(Cincinnati Children's Hospital Medical Center)
Cited by 64
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
|Cell|2008|2.6k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
The DNA sequence of the human X chromosome
|Nature|2005|1.2k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
|Archives of Pathology & Laboratory Medicine|2010|1.1k